A Bayesian framework for longitudinal EHR and genetic discovery
A new Bayesian AI framework integrates genetic data and electronic health records to predict hundreds of different diseases.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Researchers have developed a Bayesian framework for longitudinal electronic health record (EHR) and genetic discovery. Developed by MGH and Dana-Farber, the tool is designed to forecast risks for a wide array of sicknesses, including breast cancer and heart disease.
Coverage from Nature, Digital Health Wire, and Inside Precision Medicine emphasizes the model's predictive scope. Reports vary on the exact number of conditions the tool can predict, with figures ranging from 300-plus to 900 diseases.
Future developments center on the application of this model using real patient records and the integration of longitudinal EHR and genetic data for disease discovery.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
Who developed the prediction tool?
The tool was developed by MGH and Dana-Farber.
What data does the AI model use?
The model utilizes genetics and electronic health records (EHR).
How many diseases can the model predict?
According to coverage, the model predicts between 300-plus and 900 diseases.
Coverage (5)
- New Model Predicts 900 Diseases From Real Records Digital Health Wire · 5h ago
- Model Forecasts Diseases From Patient Data Mirage News · 5h ago
- AI Model Predicts 348 Diseases from Electronic Health Record, Genetics Inside Precision Medicine · 5h ago
- Scared you’ll get heart disease or breast cancer? New tool by MGH, Dana-Farber predicts risks for 300-plus sicknesses. The Boston Globe · 5h ago
- A Bayesian framework for longitudinal EHR and genetic discovery Nature · 5h ago
Topics
Related trends
Just 12 weeks of intermittent fasting may help sustain weight loss a year later: study
A new study suggests that 12 weeks of intermittent fasting may lead to sustained weight loss a year after the regimen ends.
Rapid magnetic brain stimulation eases depression within days, but benefits fade within weeks
Rare Autopsy Finds Alzheimer's Drugs Only Work in Some Parts of The Brain
A rare autopsy study suggests Alzheimer's drugs may clear amyloid in certain brain regions while affecting tau buildup and neurodegeneration.
New Israeli ultrasound procedure offers hope for enlarged prostate
A new Israeli ultrasound procedure called Aquablation is emerging as a treatment option for patients with enlarged prostates.
Late-Night Snacking Triggers Metabolic Disease in Night Owls
New research indicates that late-night snacking may trigger metabolic disease and heart health risks specifically for night owls.
New Alzheimer’s drug could stop disease
A new brainshuttle therapy from Roche is being tested for its potential to stop Alzheimer's disease, possibly before symptoms appear.